PubMed

Cardiovascular drug use and hospitalizations attributable to type 2 diabetes.

Erkens JA, Klungel OH, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG.

Diabetes Care. 2001 Aug;24(8):1428-32.PMID: 11473081 [PubMed - indexed for MEDLINE]Related articlesFree article

Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.

van der Linden MW, Plat AW, Erkens JA, Emneus M, Herings RM.

Value Health. 2009 Sep;12(6):909-14. Epub 2009 Mar 11.PMID: 19508664 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus.

Erkens JA, Herings RM, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG.

J Clin Epidemiol. 2002 Apr;55(4):345-9.PMID: 11927201 [PubMed - indexed for MEDLINE]Related articles

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.PMID: 15669880 [PubMed - indexed for MEDLINE]Related articles

Underuse of cardioprotective treatment by the elderly with type 2 diabetes.

Sirois C, Moisan J, Poirier P, Grégoire JP.

Diabetes Metab. 2008 Apr;34(2):169-76.PMID: 18396087 [PubMed - indexed for MEDLINE]Related articlesFree article

Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus.

Spoelstra JA, Stolk RP, Cohen D, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.

J Clin Psychiatry. 2004 May;65(5):674-8.PMID: 15163254 [PubMed - indexed for MEDLINE]Related articles

Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.

Kalsekar I, Iyer S, Mody R, Rajagopalan R, Kavookjian J.

J Manag Care Pharm. 2006 Mar;12(2):121-9.PMID: 16515370 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.

Lee HY, Cooke CE, Robertson TA.

J Manag Care Pharm. 2008 Apr;14(3):271-80.PMID: 18439049 [PubMed - indexed for MEDLINE]Related articlesFree article

Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

Yurgin N, Secnik K, Lage MJ.

Clin Ther. 2007 Feb;29(2):316-25.PMID: 17472823 [PubMed - indexed for MEDLINE]Related articles

Antihypertensive drug therapy and the risk of lower extremity amputations in pharmacologically treated type 2 diabetes patients.

Erkens JA, Klungel OH, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG.

Pharmacoepidemiol Drug Saf. 2004 Mar;13(3):139-46.PMID: 15072112 [PubMed - indexed for MEDLINE]Related articles

The risk of cancer in users of statins.

Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar HJ.

J Clin Oncol. 2004 Jun 15;22(12):2388-94.PMID: 15197200 [PubMed - indexed for MEDLINE]Related articles

Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.

Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C.

Circulation. 2008 Apr 15;117(15):1945-54. Epub 2008 Mar 31.PMID: 18378618 [PubMed - indexed for MEDLINE]Related articlesFree article

Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting.

Maru S, Koch GG, Stender M, Clark D, Gibowski L, Petri H, White AD, Simpson RJ Jr.

Diabetes Care. 2005 Jan;28(1):20-6.PMID: 15616228 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of an educational program on the prevalence of use of antiplatelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge in patients with coronary artery disease.

Sanal S, Aronow WS.

J Gerontol A Biol Sci Med Sci. 2003 Nov;58(11):1046-8.PMID: 14630888 [PubMed - indexed for MEDLINE]Related articles

Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?

Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.

Pharmacoepidemiol Drug Saf. 2003 Mar;12(2):121-7.PMID: 12642975 [PubMed - indexed for MEDLINE]Related articles

Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals.

Reunanen A, Kangas T, Martikainen J, Klaukka T.

Diabetes Care. 2000 Sep;23(9):1265-71.PMID: 10977017 [PubMed - indexed for MEDLINE]Related articlesFree article

Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.

Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Murray FT.

Clin Ther. 2004 Sep;26(9):1400-10.PMID: 15531002 [PubMed - indexed for MEDLINE]Related articles

Dispensing glucose test materials in Dutch community pharmacies.

Storimans MJ, Talsma H, Klungel OH, de Blaey CJ.

Pharm World Sci. 2004 Feb;26(1):52-5.PMID: 15018260 [PubMed - indexed for MEDLINE]Related articles

Outcomes associated with introduction of thiazolidinedione therapy in Medicaid enrolled patients with type 2 diabetes: an updated and expanded retrospective analysis.

Balkrishnan R, Rajagopalan R, Shenolikar RA, Camacho FT, Anderson RT.

Curr Med Res Opin. 2006 Mar;22(3):551-9.PMID: 16574038 [PubMed - indexed for MEDLINE]Related articles

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.

Evans JM, Ogston SA, Emslie-Smith A, Morris AD.

Diabetologia. 2006 May;49(5):930-6. Epub 2006 Mar 9.PMID: 16525843 [PubMed - indexed for MEDLINE]Related articles